Source clinic inventory through an eligible purchasing relationship; source patient prescriptions through an appropriate dispensing route. A published patient cash offer is not evidence of a clinic’s acquisition price or resale rights. FDA advises purchasing prescription medicines only from properly licensed and authorized wholesale distributors, while manufacturer programmes describe patient-specific offers. (fda.gov)
For a wholesale request, specify:
- Clinic legal entity, licences and shipping locations.
- Exact brand, National Drug Code where applicable, strength and presentation.
- Intended administration or dispensing model.
- Forecast quantities by presentation—not simply total patients.
- Payment terms, minimums, allocation rules and returns.
- Traceability and cold-chain responsibilities.
McKesson publishes account-request and pharmaceutical-ordering resources, but those resources do not establish GLP-1 availability for a particular clinic. (mms.mckesson.com)
No public wholesale benchmark is offered here. Obtain account-specific quotations before claiming a difference between clinic acquisition cost and patient self-pay expenditure.
Sources cited on this page
- fda.gov · Source 1 ↗https://www.fda.gov/drugs/drug-supply-chain-integrity/check-licensure-wholesale-drug-distributors-and-third-party-logistics-providers?utm_source=openai
- mms.mckesson.com · Source 2 ↗https://mms.mckesson.com/content/request-an-account/?utm_source=openai